Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

AIM ImmunoTech Inc. (AIM)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.9900+0.0500 (+5.32%)
At close: 04:00PM EDT
0.9702 +0.01 (+0.74%)
After hours: 04:03PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Previous Close0.9400
Open0.9776
Bid0.9701 x 1200
Ask0.9999 x 39400
Day's Range0.9601 - 1.0500
52 Week Range0.5500 - 2.4000
Volume431,389
Avg. Volume543,193
Market Cap47.568M
Beta (5Y Monthly)-0.59
PE Ratio (TTM)N/A
EPS (TTM)-0.4040
Earnings DateAug 10, 2022 - Aug 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.83
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AIM

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • AIM ImmunoTech Inc.
    Analyst Report: Merck & Co IncMerck & Co. is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has a leading vaccine business and an animal health division. MRK shares are included in the S&P 500.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
Advertisement
Advertisement